AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
These new models are specially trained to recognize when an LLM is potentially going off the rails. If they don’t like how an interaction is going, they have the power to stop it. Of course, every ...